OpenVSafe by OpenVAERS
Search V-safe

PGZ-32893-74962

2 vaccinations 2 coded responses 7 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
551 / MN
Registered
2021-01-04
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1008142 (opens in a new window) high 8 / 11 1 0 of 5 VAERS symptoms same dose (2) MN matches 2021-01-12 / 2021-01-13 / 2021-02-06
received the same day as the last call
 case 58436

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-04
    Registered in v-safe
  3. 2021-01-04
    Survey response — day 7, dose 1
    MedDRA: Pain of skin — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Scalp tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  6. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-02-06
    Call successful
    Completed over the phone
  11. 2021-07-17
    Survey response — 6 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Gestational diabetes
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-07-17
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-07-19
  14. 2022-01-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 unsuccessful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-04

Systemic reaction (other): Scalp tenderness

Release 9 — 6 months, dose 2

2021-07-17

Symptoms: Gestational diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGestational diabetes · · ✓
SROPain of skin ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…